Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update and latest advances in antiretroviral therapy
Luis Menéndez‐Arias, Rafaël Delgado
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 16-29
Open Access | Times Cited: 139

Showing 51-75 of 139 citing articles:

Effects of Perceived Social Support on Health-Related Quality of Life in Asymptomatic and Symptomatic People Living with HIV in China: A Cross-Sectional Study
Meilian Xie, Aiping Wang, Kerong Wang, et al.
Current HIV Research (2023) Vol. 21, Iss. 1, pp. 63-72
Closed Access | Times Cited: 4
In-house ELISA protocols for capsid p24 detection of diverse HIV isolates
Mariano A. Molina, Monique Vink, Ben Berkhout, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease
Agnieszka Lembas, Andrzej Załęski, Michał Peller, et al.
Cardiovascular Toxicology (2023) Vol. 24, Iss. 1, pp. 1-14
Open Access | Times Cited: 4
N-Substituted Bicyclic Carbamoyl Pyridones: Integrase Strand Transfer Inhibitors that Potently Inhibit Drug-Resistant HIV-1 Integrase Mutants
Pankaj S. Mahajan, Steven J. Smith, Min Li, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 3, pp. 917-927
Open Access | Times Cited: 1
Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya
Anne Kaggiah, Catherine N. Maina, John Kinuthia, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Human immunodeficiency virus infection challenges: Current therapeutic limitations and strategies for improved management through long‐acting injectable formulation
Tanushree, Aman Sharma, M. Lamba, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 1
Hospital readmissions among adults living with and without HIV in the US: findings from the Nationwide Readmissions Database
Xianming Zhu, Eshan U. Patel, Stephen A. Berry, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102690-102690
Open Access | Times Cited: 1
Population pharmacokinetics of Ainuovirine and exposure–response analysis in human immunodeficiency virus-infected individuals
Xiaoxu Han, Jin Sun, Yihang Zhang, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 20, pp. 2473-2482
Open Access | Times Cited: 1
In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae
Marina Nosik, Krylova Nv, Roza V. Usoltseva, et al.
Marine Drugs (2024) Vol. 22, Iss. 8, pp. 355-355
Open Access | Times Cited: 1
Exploring viral neuropathic pain: Molecular mechanisms and therapeutic implications
Songchao Xu, Huili Li, Zhangran Ai, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012397-e1012397
Open Access | Times Cited: 1
The Role of Peptides in Combatting HIV Infection: Applications and Insights
Naiera M. Helmy, Keykavous Parang
(2024)
Open Access | Times Cited: 1
Molecular Mechanism-Driven Discovery of Novel Small Molecule Inhibitors against Drug-Resistant SARS-CoV-2 Mpro Variants
Jingyi Yang, Beibei Fu, Rongpei Gou, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 20, pp. 7998-8009
Closed Access | Times Cited: 1
The Role of Peptides in Combatting HIV Infection: Applications and Insights
Naiera M. Helmy, Keykavous Parang
Molecules (2024) Vol. 29, Iss. 20, pp. 4951-4951
Open Access | Times Cited: 1
Antiviral Agents: Structural Basis of Action and Rational Design
Luis Menéndez‐Arias, Federico Gago
Sub-cellular biochemistry/Subcellular biochemistry (2024), pp. 745-784
Closed Access | Times Cited: 1
HIV cure: Are we going to make history?
Shuvasree Payra, Pramod Kumar Manjhi, Shruti Singh, et al.
HIV Medicine (2023) Vol. 25, Iss. 3, pp. 322-331
Open Access | Times Cited: 4
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy
Baratali Mashkani, Mohammad Jalili‐Nik, Seyed Abdolrahim Rezaee, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 12, pp. 1233-1248
Closed Access | Times Cited: 4
Repurposing drugs targeting epidemic viruses
Vigneshwaran Namasivayam, Palaniappan Senthilkumar, Murugesan Vanangamudi
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1874-1894
Closed Access | Times Cited: 7
Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis via CiteSpace
Xi Chen, Yu Lai
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Synthetic Approaches to a Key Pyridone-carboxylic Acid Precursor Common to the HIV-1 Integrase Strand Transfer Inhibitors Dolutegravir, Bictegravir, and Cabotegravir
Pankaj S. Mahajan, Terrence R. Burke
Organic Process Research & Development (2023) Vol. 27, Iss. 5, pp. 847-853
Open Access | Times Cited: 3
Dual trajectories of antiretroviral therapy adherence and polypharmacy in women with HIV in the United States
Abubaker Ibrahim Elbur, Musie Ghebremichael, Deborah Konkle‐Parker, et al.
AIDS Research and Therapy (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Patient-reported outcome measures of stigma and discrimination for people living with HIV: a systematic review protocol
Xianxia Yang, Yizhu Zhang, Shuyu Han, et al.
JBI Evidence Synthesis (2023) Vol. 21, Iss. 9, pp. 1838-1846
Open Access | Times Cited: 3
Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era
Rui Jiang, Zichen Song, Li Liu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 3
Design, synthesis, and biological evaluation of novel double-winged galloyl derivatives as HIV-1 RNase H inhibitors
Lina Zhang, Fenju Wei, David Borrego, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114563-114563
Open Access | Times Cited: 5
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8415-8415
Open Access | Times Cited: 5
Epidemiology of Treponema pallidum and HIV co-infections in the Italian blood donor population: 2009-2021.
Ilaria Pati, Carlo Mengoli, Simonetta Pupella, et al.
PubMed (2023) Vol. 21, Iss. 3, pp. 251-256
Closed Access | Times Cited: 2

Scroll to top